Fred's Inc (FRED)
$0.39 0.02 (4.75%)
16:02 EDT FRED Stock Quote Delayed 15 Minutes
Previous Close $0.39
Market Cap 14.55M
PE Ratio -0.12
Volume (Avg. Vol.) 271,500
Day's Range 0.39 - 0.45
52-Week Range 0.38 - 3.58
Dividend & Yield 0.18 (46.08%)
FRED Stock Predictions, Articles, and Fred's Inc News
- From InvestorPlace
- From the Web
Fred's earnings (FRED) were released on Thursday, with the company's loss narrowing but its net sales falling, sending FRED stock sliding.
Fred's stock was soaring Monday on news of a new deal with Walgreens (WBA) that will have it selling patient information from 185 pharmacies.
Talk is cheap. If RAD stock is ever going to live up to some expectations, Rite Aid has to do something big, and fast.
Next week, Hewlett Packard, Fred's, and Kroger will report earnings. Investors should pay attention to HPE, FRED, and KR stock.
Rite Aid has been decimated, but if investors believe the latest deal with Walgreens will go through, RAD stock has potential.
It's looking like the bottom is finally in for RAD stock. Here's how things look for Rite Aid amid the new Walgreens deal.
If you're looking for companies that are set up for a short squeeze, and perhaps soon, then these are some stocks to buy.
Rite Aid has plunged because its merger with Walgreens has morphed into something else. But that's not the only reason RAD stock is toxic.
Why Advanced Micro Devices, Inc. (AMD), Fred’s, Inc. (FRED) and Physicians Realty Trust (DOC) Are 3 of Today’s Worst Stocks
Fred's (FRED), Physicians Realty Trust (DOC) and Advanced Micro Devices (AMD) investors couldn't wait for Thursday's closing bell to ring.
Walgreens didn't need to buy Rite Aid. Instead, it bought the the assets it most covets, and WBA stock holders are doing cartwheels.
Walgreens scraps its merger plans with Rite Aid and will buy 2,000-plus stores instead. RAD stock is plunging Thursday, as one would expect.
Rite Aid will either merge into Walgreens, find another buyer or disappear. Those buying RAD stock today should expect a sale soon.
Shares of Rite Aid have suffered this year, but just because a buyout is still on the table doesn't mean investors should buy RAD stock.
Buy Realty Income now because it's yielding 4.5%. Hold onto O stock for the long haul because that payout is going to grow.
RAD stock was pummeled on Friday amid reports that the FTC is planning to tell Walgreens it can't throw Rite Aid a much-needed lifeline.
Rite Aid (RAD) has been cruising lower as doubts linger about a buyout from Walgreens. Unfortunately, RAD stock is just for speculation.
Rite-Aid (RAD) has perked up since last month's earnings report, but that doesn't mean RAD stock is actually worth fooling with.
Buying Rite Aid (RAD) shares now could be a rewarding play. Even if the Walgreens merger gets blocked, RAD stock could hit the $6 mark.
Recent 13-D and 13-G filings are a window into activist investor activity. We look at BlackRock (BLK) and 11 other filings
Rite Aid (RAD) pulled off top- and bottom-line beats for fiscal Q4, showing that the drug store chain is performing better than RAD stock.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!